You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 149 No. 4, April 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL OBSERVATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Hyperthyroxinemia in Patients Receiving Thyroid Replacement Therapy

Frank M. Grund, MD; Catherine B. Niewoehner, MD

Arch Intern Med. 1989;149(4):921-924.


Abstract

• Eleven patients, with a history of hypothyroidism, who had hyperthyroxinemia and an elevated free thyroxine index but normal serum triiodothyronine concentrations on levothyroxine replacement underwent levothyroxine dose reduction at three-month intervals until the free thyroxine index fell into the normal range. All were clinically euthyroid throughout. Normalization of the thyrotropin response to thyrotropinreleasing hormone occurred concomitantly, indicating correction of subtle hyperthyroidism. The mean thyroxine dose decreased from 161 µg/d (2.06 µg/kg) to 120 µg/d (1.51 µg/kg). The resting heart rate fell in eight of 11 patients (P<.02). The left ventricular ejection fraction decreased in eight of 11 patients, although the decrease was not statistically significant. Considering the sensitivity of pituitary, cardiac, and bone tissue to even a small excess of thyroxine over time, hyperthyroxinemia associated with an elevated free thyroxine index should be corrected even in patients taking levothyroxine replacement who are clinically euthyroid and whose serum triiodothyronine concentrations are within normal limits.

(Arch Intern Med 1989;149:921-924)



Author Affiliations

From the Department of Nuclear Medicine (Dr Grund) and Endocrine Metabolic Section (Dr Niewoehner), Veterans Administration Medical Center, and the Departments of Medicine (Drs Grund and Niewoehner) and Radiology (Dr Grund), University of Minnesota, Minneapolis.


Footnotes

Accepted for publication Oct 26, 1988.

Reprint requests to Department of Nuclear Medicine, Veterans Administration Medical Center, 54th Street and 48th Avenue South, Minneapolis, MN 55417 (Dr Grund).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Subclinical hyperthyroidism: clinical features and treatment options
Biondi et al.
Eur J Endocrinol 2005;152:1-9.
ABSTRACT | FULL TEXT  

Subclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management
Surks et al.
JAMA 2004;291:228-238.
ABSTRACT | FULL TEXT  

Effects of Subclinical Thyroid Dysfunction on the Heart
Biondi et al.
ANN INTERN MED 2002;137:904-914.
ABSTRACT | FULL TEXT  

Risk for Fracture in Women with Low Serum Levels of Thyroid-Stimulating Hormone
Bauer et al.
ANN INTERN MED 2001;134:561-568.
ABSTRACT | FULL TEXT  

Low Thyrotropin Levels Are Not Associated with Bone Loss in Older Women: A Prospective Study
Bauer et al.
J. Clin. Endocrinol. Metab. 1997;82:2931-2936.
ABSTRACT | FULL TEXT  

Monitoring Therapy in Patients Taking Levothyroxine
Helfand and Crapo
ANN INTERN MED 1990;113:450-454.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.